"EFFECTS OF KINESIO-TAPING ON PAIN, POSTURAL STABILITY AND FUNCTION IN PERSONS WITH DISCOGENIC LOW BACK PAIN"

January 26, 2023 updated by: Foundation University Islamabad
Low back pain is the leading cause of disability worldwide, the prevalence of low back pain can be as high as 43%. Past research has shown the positive effects of Kinesio taping in patients with chronic and nonspecific low back pain in pain reduction, improvement in postural stability, and improvement in function. However, no study has yet evaluated the effects of KT in persons with discogenic LBP. If found to be effective KT can be prescribed as a conservative & cost-effective treatment for patients with discogenic low back pain.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Federal
      • Islamabad, Federal, Pakistan, 46000
        • Foundation University Islamabad

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 45 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age20-45 years.
  • Positive straight leg raise (SLR)
  • Posterolateral disc bulge, herniation or prolapse indicated by MRI.
  • Positive centralization and peripheralization phenomenon.

Exclusion Criteria:

  • Participants having spondylolisthesis, fractures, tumors, osteoporosis, infection, or spinal stenosis.
  • History of lumbar spine surgery and patients that are already receiving any physical therapy or exercise
  • Skin allergy or sensitivity to the tape.
  • Neurological, rheumatologic, or psychiatric disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Active Comparator
  • IFC + Hot pack for 20 minutes
  • MDT (prone positioning) for 10 minutes.
  • Lumbar SNAGs + lumbar rotation mobilization.
  • Home exercise plan: MDT for 10 min + patient education to avoid flexion based activities.
  • Sham Kinesiotape will be applied
Procedure: Control Treatment
IFC + Hot pack for 20 minutes MDT (prone positioning) for 10 minutes. Lumbar SNAGs + lumbar rotation mobilization. Home exercise plan: MDT for 10 min + patient education to avoid flexion based activities.
EXPERIMENTAL: Experimental Group
  • IFC + Hot pack for 20 minutes
  • MDT (Prone positioning) for 10 minutes.
  • Lumbar SNAGs + lumbar rotation mobilization.
  • Home exercise plan: MDT for 10 min + patient education to avoid flexion based activities.
  • Kinesiotape will be applied
Procedure: Kinesiotaping
Kinesiotape will be applied

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Back Pain
Time Frame: 2 weeks.
Back Pain will be measured via numerical pain rating scale. A higher score signifies greater pain.
2 weeks.
Postural Stability
Time Frame: 2 weeks.
Postural Stability will be measured via Biodex Balance System. A higher score signifies poorer stability.
2 weeks.
Disability
Time Frame: 2 weeks.
Disability will be measured via Oswestry Disability Index. A higher score signifies poorer outcome.
2 weeks.
Gait velocity
Time Frame: 2 weeks.
velocity of gait will be measured via gait analysis.
2 weeks.
Stride length
Time Frame: 2 weeks.
Stride length of gait will be measured via gait analysis.
2 weeks.
Cadence
Time Frame: 2 weeks.
Cadence of gait will be measured via gait analysis.
2 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Foundation University Islamabad

Investigators

  • Principal Investigator: Sameen Tariq, DPT, Foundation University Islamabad
  • Study Director: Muhammad Osama, PhD*, Foundation University Islamabad

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

February 15, 2023

Primary Completion (ANTICIPATED)

August 15, 2023

Study Completion (ANTICIPATED)

August 30, 2023

Study Registration Dates

First Submitted

January 26, 2023

First Submitted That Met QC Criteria

January 26, 2023

First Posted (ACTUAL)

February 6, 2023

Study Record Updates

Last Update Posted (ACTUAL)

February 6, 2023

Last Update Submitted That Met QC Criteria

January 26, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FUI/CTR/2023/4

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Control Treatment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe